Provided by Tiger Trade Technology Pte. Ltd.

ARK Genomic Revolution ETF

46.69
-0.9500-1.99%
Volume:1.71M
Turnover:79.69M
Market Cap:2.00B
PE:- -
High:47.28
Open:47.18
Low:46.13
Close:47.64
52wk High:50.54
52wk Low:24.20
Shares:42.75M
Float Shares:42.75M
Volume Ratio:1.02
T/O Rate:4.01%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tempus AI is Maintained at Hold by Freedom Capital Markets

Dow Jones
·
3 hours ago

Maxell to Dispose Treasury Shares for Director Share-Based Pay Plan

TIPRANKS
·
8 hours ago

NOVONIX Details Global Corporate Structure and Dual Market Listings

TIPRANKS
·
11 hours ago

Advance ZincTek Maps Out Compliance With ASX Governance Standards

TIPRANKS
·
11 hours ago

Luckland Speeds Up Disclosure of Financial Briefing Materials

TIPRANKS
·
15 hours ago

Tempus AI (TEM) Could Be 18% Below Fair Value As FDA Clearance Lands

Simply Wall St.
·
Yesterday

CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data

Simply Wall St.
·
Yesterday

Shah Metacorp Publishes Postal Ballot, E-Voting Notice in Line with SEBI Norms

TIPRANKS
·
Yesterday

Crispr Therapeutics AG (CRSP) Gets a Buy from William Blair

TIPRANKS
·
Aug 29

10x Genomics CEO Serge Saxonov Sells USD 665,997 of Common Shares

Reuters
·
Aug 29

Qiagen Owes 10x, Roche $4.8 Million for Infringing Patents, U.S. Jury Says

Reuters
·
Aug 29

Energy Fuels Closes ASM Deal to Advance Western Mine-to-Magnet Rare Earth Supply Chain

TIPRANKS
·
Aug 29

Sector Update: Healthcare

MT Newswires Live
·
Aug 29

10x Genomics reports patent infringement win against Parse Biosciences

TIPRANKS
·
Aug 29

10x Genomics Wins Jury Verdict Against Parse in Delaware Patent Case, Awarded over $4.8 Million

Reuters
·
Aug 29

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences

THOMSON REUTERS
·
Aug 29

10x Genomics - to Seek Enhanced Damages and Permanent Injunction Against Parse in U.S.

THOMSON REUTERS
·
Aug 29

10x Genomics - Jury Awards Co over $4.80 Mln in Damages for Infringing Sales Feb 2021-June 30, 2026

THOMSON REUTERS
·
Aug 29

Paradigm Biopharmaceuticals lodges updated ASX corporate governance disclosures

TIPRANKS
·
Aug 28

Tempus AI CEO, Chairman Eric Lefkofsky Reports Disposal of Common Shares Worth $12.43 Million

Reuters
·
Aug 28